EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Importance of multi-lineage hematologic involvement and hypoalbuminemia at diagnosis in patients with "risk-organ" multi-system Langerhans cell histiocytosis



Importance of multi-lineage hematologic involvement and hypoalbuminemia at diagnosis in patients with "risk-organ" multi-system Langerhans cell histiocytosis



Journal of Pediatric Hematology/Oncology 32(4): E122-E125



To perform a risk factor analysis in patients with "risk organ" multi-system Langerhans cell histiocytosis at diagnosis. From 1987 to 2007, 77 patients were analyzed. A univariate analysis of the variables, age <2 years, lungs, spleen and hepatic involvement, presence of >or=2 risk involved organs, hypoalbuminemia and the presence of isolated anemia, anemia with thrombocytopenia with or without leukopenia at diagnosis was performed. Statistically significant variables were combined and entered into a multivariate analysis. Fifty-six and 66 evaluable patients had hematologic and hepatic involvement at diagnosis, respectively. Among the hematologic patients, the subgroup of anemia with thrombocytopenia with or without leukopenia showed a significantly lower 5-year survival than the subgroup of isolated anemia (0.19 vs. 0.87, respectively; P=0.0001). Of all the patients, those with hypoalbuminemia had a 5-year survival of 0.16 compared with those with normal albumin levels, who had a 5-year survival of 0.65 (P<0.0001). In multivariate analysis, only anemia with thrombocytopenia with or without leukopenia and hypoalbuminemia were the independent risk factors (relative risk 3.77; confidence interval, 1.7-8.4; P<0.0011 and relative risk 2.59; confidence interval, 1.24-5.4; P<0.0112). Anemia with thrombocytopenia with or without leukopenia and hypoalbuminemia, were associated with worse prognosis in multi-system Langerhans cell histiocytosis. Other therapeutic strategies should be considered at diagnosis or early during the initial treatment for this high risk subgroup of patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 053740206

Download citation: RISBibTeXText

PMID: 20418784

DOI: 10.1097/MPH.0b013e3181d7acc5



Related references

Gastrointestinal involvement in langerhans cell histiocytosis: consider treatment as for multi-system disease. Archives of Disease in Childhood 97(Suppl 1): A58-A58, 2012

Impact of reactivation on the sequelae of multi-system Langerhans cell histiocytosis patients. Pediatric Blood & Cancer 50(4): 931-2; Author Reply 932, 2007

Adult multi-organ Langerhans cell histiocytosis with fatal outcome. Annales de Dermatologie et de Venereologie 140(5): 410-413, 2013

Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Pediatric Blood & Cancer 62(12): 2162-2166, 2016

Rapidly progressing fatal adult multi-organ Langerhans cell histiocytosis complicated with fatty liver disease. Journal of Clinical and Experimental Hematopathology 52(2): 121-126, 2013

Clinical study of 131 children with multi-system Langerhans cell histiocytosis. Zhonghua Er Ke Za Zhi 54(5): 349-353, 2016

Langerhans cell histiocytosis presenting as a multi-system disorder in an infant. International Journal of Dermatology 51(6): 709-712, 2012

An unusual case of adult-onset multi-systemic Langerhans cell histiocytosis with perianal and incident thyroid involvement. Endocrinology, Diabetes & Metabolism Case Reports 2017, 2017

Cognitive outcome in long-term survivors of multi-system Langerhans cell Histiocytosis. Medical & Pediatric Oncology 36(3): 424, March, 2001

A rare case of "switch on and off" multi-system Langerhans cell histiocytosis in an adult patient. Journal of Medical Case Reports 5(): 302-302, 2011

Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis. British Journal of Haematology 132(6): 784-787, 2006

Acute-phase ITIH4 levels distinguish multi-system from single-system Langerhans cell histiocytosis via plasma peptidomics. Clinical Proteomics 12(1): 16-16, 2015

Central nervous system involvement in Langerhans cell histiocytosis: the importance of long term follow-up. Pediatric Blood & Cancer 56(2): 175-176, 2011

Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105(3): 9-77, 2001

Long term morbidity and health related quality of life after multi-system Langerhans cell histiocytosis. European Journal of Cancer 42(15): 2563-2569, 2006